Overview

Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in India

Status:
Completed
Trial end date:
2018-04-23
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of sofosbuvir (SOF)-based regimens administered as per the approved prescribing information in adults with chronic hepatitis C virus (HCV) infection treated in routine clinical practice in India.
Details
Lead Sponsor:
Gilead Sciences
Treatments:
Sofosbuvir